Clinical Research Alliance

New Hyde Park, New York 11042

0 studies enrolling now · 3 studies all time

What they study most

Chronic Lymphocytic Leukemia, Lymphoma, Non Hodgkin Lymphoma

Studies at this site

• An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma — Stopped early
• A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL) — Stopped early
• A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204) — Completed